Literature DB >> 24361765

Increased risk of suicidality on perampanel (Fycompa®)?

Bernd Huber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24361765     DOI： 10.1016/j.yebeh.2013.11.017

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN： 1525-5050            Impact factor:   2.937


× No keyword cloud information.
  4 in total

1.  Perampanel-associated self-harm ideation after dosage increase.

Authors:  Farid Kheloufi; Anne Default; Bruno Perrouty; Olivier Blin; Joëlle Micallef
Journal:  Eur J Clin Pharmacol       Date:  2017-11-11       Impact factor: 2.953

Review 2.  The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.

Authors:  Paul LaPenna; Laura M Tormoehlen
Journal:  J Med Toxicol       Date:  2017-08-16

Review 3.  Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.

Authors:  Martin J Brodie
Journal:  CNS Drugs       Date:  2015-11       Impact factor: 5.749

Review 4.  Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability.

Authors:  Andreas Schulze-Bonhage; Mandy Hintz
Journal:  Patient Prefer Adherence       Date:  2015-08-11       Impact factor: 2.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.